国家药监局：助推化妆品产业高质量发展

Core Viewpoint - The National Medical Products Administration (NMPA) has released an opinion aimed at deepening cosmetic regulation reform to promote high-quality development in the industry, outlining 24 reform measures across five key areas [1]. Group 1: Reform Measures - The opinion emphasizes encouraging innovation within the cosmetic industry [1]. - It proposes optimizing registration and filing management to streamline processes [1]. - Strengthening risk prevention and control across the entire supply chain is highlighted as a critical measure [1]. - The opinion aims to enhance intelligent regulatory capabilities to improve oversight [1]. - Promoting alignment of regulations with international standards is also a key focus [1]. Group 2: Future Goals - By 2030, the regulatory legal framework for cosmetics is expected to be more complete, with a more robust standard system and stronger technical support [1]. - The industry is anticipated to exhibit increased innovation vitality and enhanced risk prevention capabilities by 2030 [1]. - By 2035, the cosmetic quality and safety regulatory system is projected to reach international advanced levels, with improved innovation and global competitiveness [1].